— Know what they know.
Not Investment Advice

BIO.AX ASX

Biome Australia Limited
1W: +3.7% 1M: +18.3% 3M: +58.5% YTD: -3.5% 1Y: -18.4% 3Y: +236.0%
A$0.40 ($0.28)
-0.02 (-4.76%)
 
Weekly Expected Move ±8.9%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 67 · A$95.8M mcap · 147M float · 0.208% daily turnover

Income Trends

Revenue
$24M +29.7% ▲
5Y CAGR: +59.4%
Gross Profit
$7M -40.1% ▼
5Y CAGR: +44.4%
Operating Income
$2M +545.7% ▲
Net Income
$4M +1580.9% ▲
EPS (Diluted)
$0.02 +1490.0% ▲
EBITDA
$2M +1397.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$4M$7M$13M$18M$24M
YoY Growth+77.4%+75.9%+79.8%+41.6%+29.7%
Cost of Revenue$2M$3M$5M$7M$17M
Gross Profit$2M$4M$8M$11M$7M
Gross Margin57.8%56.0%60.8%61.1%28.2%
R&D Expenses$0$0$0$0$0
SG&A Expenses$6M$7M$10M$11M$5M
Operating Expenses$7M$7M$10M$11M$5M
Operating Income-$4M-$3M-$2M$278K$2M
Operating Margin-102.4%-45.3%-12.9%1.5%7.5%
Interest Expense$33K$31K$165K$197K$115K
Income Before Tax-$5M-$3M-$2M$215K$530K
Tax Expense-$223K-$328K-$315K$0-$3M
Net Income-$5M-$3M-$2M$215K$4M
Net Margin-110.4%-42.5%-12.8%1.2%15.1%
EPS (Diluted)$-0.02$-0.02$-0.01$0.00$0.02
EBITDA-$5M-$3M-$2M$144K$2M
Shares Outstanding200M201M208M218M227M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms